(Q43884231)

27 November 2017

title

Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans (English)

1 reference

27 November 2017

8

Michael Camilleri

1 reference

27 November 2017

Silvia Delgado-Aros

1

1 reference

27 November 2017

Doe-Young Kim

2

1 reference

27 November 2017

Duane D Burton

3

1 reference

27 November 2017

George M Thomforde

4

1 reference

27 November 2017

Debra Stephens

5

1 reference

27 November 2017

Benjamin H Brinkmann

6

1 reference

27 November 2017

Adrian Vella

7

1 reference

27 November 2017

publication date

1 March 2002

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

27 November 2017

published in

1 reference

27 November 2017

volume

282

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

G424-31

1 reference

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Impaired accommodation of proximal stomach to a meal in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Gastric emptying of liquids and solids: roles of proximal and distal stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Development of a test to measure gastric accommodation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

The relationship between technetium 99m pertechnetate gastric scanning and gastric contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Meckel's diverticulum: imaging diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Evidence that nitric oxide mechanisms regulate small intestinal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Responses to gastric distension in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Gastric emptying and release of incretin hormones after glucose ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

The Effect of Glucagon-Like Peptide I (GLP-I) on Glucose Elimination in Healthy Subjects Depends on the Pancreatic Glucoregulatory Hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2002.282.3.G424

10.1152/AJPGI.2002.282.3.G424

21 January 2018

Identifiers

DOI

0 references

1 reference